Search research articles
Contact Us
Filters
Showing results (11-20 of 55) with videos related to
Page
of 6
Sort By:
Cells
|
November 27, 2024
Dysregulation of miRNAs in Soft Tissue Sarcomas
Stefano Zoroddu, Angela Lucariello, Antonio De Luca, et al.
Cell Cycle (Georgetown, Tex.)
|
August 30, 2007
Interaction between the Cdk2/cyclin A complex and a small molecule derived from the pRb2/p130 spacer domain: a theoretical model
Antonio Giordano, Emanuele Bellacchio, Luigi Bagella, et al.
Journal of Cellular Biochemistry
|
November 6, 2007
From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway
Ang Sun, Luigi Bagella, Steven Tutton, et al.
Journal of Cellular Physiology
|
December 19, 2009
Cytometry and DNA ploidy: clinical uses and molecular perspective in gastric and lung cancer
Vittorio D'Urso, Angelo Collodoro, Eliseo Mattioli, et al.
Journal of Cellular Physiology
|
March 26, 2018
The role of enhancer of zeste homolog 2: From viral epigenetics to the carcinogenesis of hepatocellular carcinoma
Luca Sanna, Irene Marchesi, Mariarosa A B Melone, et al.
Journal of Cellular Physiology
|
September 6, 2007
Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements
Tiziana Tonini, Giuseppina D'Andrilli, Alfredo Fucito, et al.
Oncogene
|
April 13, 2004
Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A
Tiziana Tonini, Luigi Bagella, Giuseppina D'Andrilli, et al.
Journal of Cellular Physiology
|
October 26, 2005
MyoD recruits the cdk9/cyclin T2 complex on myogenic-genes regulatory regions
Cristina Giacinti, Luigi Bagella, Pier Lorenzo Puri, et al.
Cell Cycle (Georgetown, Tex.)
|
September 18, 2012
The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation
Irene Marchesi, Francesco Paolo Fiorentino, Flavio Rizzolio, et al.
International Journal of Molecular Sciences
|
December 19, 2020
BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells
Francesco Paolo Fiorentino, Irene Marchesi, Christoph Schröder, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 55) with videos related to
Sort By:
Page
of 6
Cells
|
November 27, 2024
Dysregulation of miRNAs in Soft Tissue Sarcomas
Stefano Zoroddu, Angela Lucariello, Antonio De Luca, et al.
Cell Cycle (Georgetown, Tex.)
|
August 30, 2007
Interaction between the Cdk2/cyclin A complex and a small molecule derived from the pRb2/p130 spacer domain: a theoretical model
Antonio Giordano, Emanuele Bellacchio, Luigi Bagella, et al.
Journal of Cellular Biochemistry
|
November 6, 2007
From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway
Ang Sun, Luigi Bagella, Steven Tutton, et al.
Journal of Cellular Physiology
|
December 19, 2009
Cytometry and DNA ploidy: clinical uses and molecular perspective in gastric and lung cancer
Vittorio D'Urso, Angelo Collodoro, Eliseo Mattioli, et al.
Journal of Cellular Physiology
|
March 26, 2018
The role of enhancer of zeste homolog 2: From viral epigenetics to the carcinogenesis of hepatocellular carcinoma
Luca Sanna, Irene Marchesi, Mariarosa A B Melone, et al.
Journal of Cellular Physiology
|
September 6, 2007
Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements
Tiziana Tonini, Giuseppina D'Andrilli, Alfredo Fucito, et al.
Oncogene
|
April 13, 2004
Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A
Tiziana Tonini, Luigi Bagella, Giuseppina D'Andrilli, et al.
Journal of Cellular Physiology
|
October 26, 2005
MyoD recruits the cdk9/cyclin T2 complex on myogenic-genes regulatory regions
Cristina Giacinti, Luigi Bagella, Pier Lorenzo Puri, et al.
Cell Cycle (Georgetown, Tex.)
|
September 18, 2012
The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation
Irene Marchesi, Francesco Paolo Fiorentino, Flavio Rizzolio, et al.
International Journal of Molecular Sciences
|
December 19, 2020
BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells
Francesco Paolo Fiorentino, Irene Marchesi, Christoph Schröder, et al.
Page
of 6